Product Code: ETC8274965 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Central Nervous System (CNS) Stimulants Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Central Nervous System (CNS) Stimulants Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Central Nervous System (CNS) Stimulants Market - Industry Life Cycle |
3.4 Mexico Central Nervous System (CNS) Stimulants Market - Porter's Five Forces |
3.5 Mexico Central Nervous System (CNS) Stimulants Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.6 Mexico Central Nervous System (CNS) Stimulants Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Mexico Central Nervous System (CNS) Stimulants Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Mexico Central Nervous System (CNS) Stimulants Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Mexico Central Nervous System (CNS) Stimulants Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Mexico Central Nervous System (CNS) Stimulants Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Mexico |
4.2.2 Growing awareness and diagnosis of CNS-related conditions |
4.2.3 Rise in research and development activities for CNS stimulants |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approvals in Mexico |
4.3.2 High cost associated with CNS stimulant medications |
4.3.3 Potential side effects and safety concerns related to CNS stimulants |
5 Mexico Central Nervous System (CNS) Stimulants Market Trends |
6 Mexico Central Nervous System (CNS) Stimulants Market, By Types |
6.1 Mexico Central Nervous System (CNS) Stimulants Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Mexico Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Mexico Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Phendimetrazine, 2021- 2031F |
6.1.4 Mexico Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Phentermine, 2021- 2031F |
6.1.5 Mexico Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Methamphetamine, 2021- 2031F |
6.1.6 Mexico Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Dextroamphetamine, 2021- 2031F |
6.1.7 Mexico Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Mexico Central Nervous System (CNS) Stimulants Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Mexico Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Major Depressive Disorder, 2021- 2031F |
6.2.3 Mexico Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Anxiety Disorders, 2021- 2031F |
6.2.4 Mexico Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Attention Deficit Hyperactivity Disorder, 2021- 2031F |
6.2.5 Mexico Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Mexico Central Nervous System (CNS) Stimulants Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Mexico Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Mexico Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Injectable, 2021- 2031F |
6.3.4 Mexico Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Mexico Central Nervous System (CNS) Stimulants Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Mexico Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Mexico Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Mexico Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Mexico Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Mexico Central Nervous System (CNS) Stimulants Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Mexico Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Mexico Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Mexico Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Mexico Central Nervous System (CNS) Stimulants Market Import-Export Trade Statistics |
7.1 Mexico Central Nervous System (CNS) Stimulants Market Export to Major Countries |
7.2 Mexico Central Nervous System (CNS) Stimulants Market Imports from Major Countries |
8 Mexico Central Nervous System (CNS) Stimulants Market Key Performance Indicators |
8.1 Number of clinical trials for new CNS stimulant drugs in Mexico |
8.2 Adoption rate of non-pharmacological interventions for CNS disorders |
8.3 Percentage of healthcare professionals trained in diagnosing and treating CNS conditions |
9 Mexico Central Nervous System (CNS) Stimulants Market - Opportunity Assessment |
9.1 Mexico Central Nervous System (CNS) Stimulants Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.2 Mexico Central Nervous System (CNS) Stimulants Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Mexico Central Nervous System (CNS) Stimulants Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Mexico Central Nervous System (CNS) Stimulants Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Mexico Central Nervous System (CNS) Stimulants Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Mexico Central Nervous System (CNS) Stimulants Market - Competitive Landscape |
10.1 Mexico Central Nervous System (CNS) Stimulants Market Revenue Share, By Companies, 2024 |
10.2 Mexico Central Nervous System (CNS) Stimulants Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |